Synthesis, characterization and the release kinetics of antiproliferative agents from polyamidoamine conjugates

References

• Aft R. Bisphosphonates in breast cancer: Clinical activity and implications of preclinical data. Clin Adv Hematol Oncol, 2010;9:194–205
   Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm, 2007;4:807–18
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Girija AR, Nagaoka Y, Iwai S, Suzuki M, Kizhikkilot MSV, Yoshida Y, Maekawa T, Nair SD. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: A synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int J Nanomed, 2014;9:437–59
   PubMed Web of Science ®Google Scholar
• Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, Rwakimari JB, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, Staedke SG. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda, PLoS Clin Trials, 2006;1:e7
   PubMedGoogle Scholar
• Combination therapy. Available at: http://en.wikipedia.org/wiki/Combination_therapy. Accessed 24 June 2013
   Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 2001;13:123–33
   PubMed Web of Science ®Google Scholar
• Crystalline and amorphous polymers. Available at: http://www.doitpoms.ac.uk/tlplib/polymers/crystalline.php. Accessed 3 July 2013
   Google Scholar
• Dash S, Murthy PN, Natha L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Polon Pharm Drug Res, 2010;67:217–23
   PubMed Web of Science ®Google Scholar
• Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, van Niekerk C, Everitt D, Winter H, Becker P, et al. 14-Day bactericidal activity of PA-824, bedaquiline, pyrazinamide and moxifloxacin combinations: A randomised trial. Lancet, 2012;380:986–93 (original text)
   PubMed Web of Science ®Google Scholar
• Dinh T. The advantages of combination chemotherapy. Available at: http://www.livestrong.com/article/74071-advantages-combination-chemotherapy. Accessed 14 March 2013
   Google Scholar
• Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov, 2003;2:347–60
   PubMed Web of Science ®Google Scholar
• Dunford JE. Molecular targets of the nitrogen containing bisphosphonates: The molecular pharmacology of prenyl synthase inhibition. Curr Pharm Des, 2010;16:2961–9
   PubMed Web of Science ®Google Scholar
• Garner P, Graves PM. The benefits of artemisinin combination therapy for malaria extend beyond the individual patient. PLoS Med, 2005;2:e105
   PubMed Web of Science ®Google Scholar
• Joshi HN. Recent advances in drug delivery systems: Polymeric prodrugs. Pharm Tech, 1988;12:118–30
   Google Scholar
• Joshi JR, Patel RP. The role of biodegradable polymers in drug delivery. Int J Curr Pharm Res, 2012;4, ISSN 0975-7066
   Google Scholar
• Juliano RL. 1987. Biological approaches to the controlled delivery of drugs. New York: New York Academy of Sciences, p. 507
   Google Scholar
• Kieczykowski GR, Jobson RB, Melillo DG, Reinhold DF, Grenda VJ, Shinkai I. Preparation of (4-amino-1-hydroxybutylidene)bisphosphonic acid sodium salt, MK-217 (alendronate sodium). An improved procedure for the preparation of 1-hydroxy-1,1-bisphosphonic acids. J Org Chem, 1995;60:8310–12
   Web of Science ®Google Scholar
• Krishna Mohan PR, Sreelakshmi G, Muraleedharan CV, Joseph R. Water soluble complexes of curcumin with cyclodextrins: Characterization by FT-Raman spectroscopy. Vib Spetrosc, 2012;62:77–84
   Web of Science ®Google Scholar
• Liu D, Kramer SA, Huxford-Phillips RC, Wang S, Rocca JD, Lin W. Coercing bisphosphonates to kill cancer cells with nanoscale coordination Q2 polymers. Chem Commun (Camb), 2012;48:2668–70
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release, 2000;65:271–84
   PubMed Web of Science ®Google Scholar
• Morgan G, Lipton A. Antitumor effects and anticancer applications of bisphosphonates. Semin Oncol, 2010;37:S30–40
   PubMed Web of Science ®Google Scholar
• Neuse EW. Synthetic polymers as drug-delivery vehicles in medicine. Metal-Based Drugs, 2008 Article ID 469531, 19 pp. doi:10.1155/2008/469531
   Google Scholar
• Neville-Webbe HL, Holen I, Coleman RE. The anti-tumour activity of bisphosphonates. Cancer Treat Rev, 2002;28:305–19
   PubMed Web of Science ®Google Scholar
• Nkazi BD, Neuse EW, Aderibigbe BA. Polymeric co-conjugates of curcumin. J Inorg Organomet Polym, 2012;22:886–91
   Web of Science ®Google Scholar
• Peppas NA. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv, 1985;60:110–11
   PubMedGoogle Scholar
• Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics, 2007;119(Suppl. 2):S150
   PubMed Web of Science ®Google Scholar
• Sachdeva MS. Drug targeting systems for cancer chemotherapy. Expert Opin Investig Drug, 1998;7:1849–64
   PubMedGoogle Scholar
• Shakibaei M, Mobasheri A, Lueders C, Busch F, Shayan P, Goel A. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-kB and Src protein kinase signaling pathways. PLoS One, 2013;8:e57218
   PubMed Web of Science ®Google Scholar
• Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. Cochrane Database Syst Rev, 2006;19:CD004535
   Google Scholar
• Van Beek E, Löwik C, Van der Pluijm G, Papapoulos SJ. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates. Bone Miner Res, 1999;14:722–9
   PubMed Web of Science ®Google Scholar
• Wang Y-J, Pan M-H, Cheng A-L, Lin L-I, Ho Y-S, Hsieh C-Y, Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal, 1997;15:1867–76
   PubMed Web of Science ®Google Scholar
• WHO. 2006. Guidelines for the treatment of malaria. WHO/HTM/MAL/2006.1108. Geneva: WHO
   Google Scholar
• WHO. 1998. WHO model prescribing information: Drugs used in leprosy, WHO/DMP/DSI/98.1. Geneva: WHO
   Google Scholar
• Wisema V, Kim M, Mutabingwa TK, Whitty CJM. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med, 2006;3:e373
   PubMedGoogle Scholar
• Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, et al. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med, 2005;2:e190
   PubMed Web of Science ®Google Scholar